https://transmembranetransport....ers-inhibitor.com/in
.05). Chinese OCCC patients' somatic genomic profiles were investigated, showing variations in genomic alterations across tumor stages, contrasting stage I with stage II/III/IV. Clinical factors might be complemented by genetic elements within nomogram models for forecasting progress-free survival. A study of somatic genomic alterations in Chinese OCCC patients revealed significant differences betw
Like
Comment
Share
